1.This Act may be cited as the
Diabetes Treatment and Prevention Act
of 2007
.
2.Congress makes the following
findings:
(1)According to the
Centers for Disease Control and Prevention, the prevalence of diabetes in the
United States has more than doubled in the past quarter-century.
(2)The American
Diabetes Association reports that there are now more than 20,000,000 Americans
living with diabetes, with 6,000,000 of these cases not yet diagnosed. Another
54,000,000 Americans have pre-diabetes
, which means that they
have higher than normal blood glucose levels, and are at increased risk of
developing diabetes.
(3)In 2002, the
landmark Diabetes Prevention Program study found that lifestyle changes, such
as diet and exercise, can prevent or delay the onset of type 2 diabetes, and
that participants who made such lifestyle changes reduced their risk of getting
type 2 diabetes by 58 percent.
(4)The New York
Times has reported that lifestyle-based interventions to control diabetes have
resulted in positive outcomes for patients, yet despite these successes, such
interventions were often unsustainable. While insurance companies cover the
treatments of complications of unchecked diabetes, they tend not to cover the
cheaper interventions to prevent such complications.
(5)According to the
American Diabetes Association, in 2002, direct medical expenditures for
diabetes totaled $91,800,000,000, including $23,200,000,000 for diabetes care,
and $24,600,000,000 for chronic complications attributable to diabetes. In that
year, approximately 1 out of every 10 health care dollars was directed to
diabetes.
(6)There is a need
to increase the availability of effective community-based lifestyle programs
for diabetes prevention and the ability of health care providers to refer
patients for enrollment in such programs to prevent diabetes, reduce
complications, and lower the costs associated with diabetes treatment in the
United States, and our Government should encourage efforts to replicate the
results of the Diabetes Prevention Program on a wider scale.
3.Centers for
Disease Control and Prevention Division of Diabetes Translation; diabetes
demonstration projectsTitle
III of the Public Health Service Act (42 U.S.C. 241 et seq.) is amended by
inserting after section 317S the following:
317T.Centers for
Disease Control and Prevention Division of Diabetes Translation
(a)The Director of the Centers for Disease Control and
Prevention shall establish within such Centers a Division of Diabetes
Translation to eliminate the preventable burden of diabetes.
(b)The
Division of Diabetes Translation shall carry out the following
activities:
(1)Supporting and
carrying out diabetes surveillance.
(2)Conducting
applied translational research, including research that will improve early
detection, prevention, and access to quality care with respect to
diabetes.
(3)Working with
States to establish and improve diabetes control and prevention
programs.
(4)Coordinating the
National Diabetes Education Program in conjunction with the National Institutes
of Health.
(5)Increasing
education and awareness of diabetes.
(6)Promoting greater
awareness of the health effects of uncontrolled diabetes.
(7)Other activities
as deemed appropriate by the Director.
(c)There
are authorized to be appropriated to carry out the activities of the Division
of Diabetes Translation under this section $90,000,000 for fiscal year 2008,
and such sums as may be necessary for each subsequent fiscal year.
317U.Demonstration
projects for the identification and treatment for persons diagnosed with or at
high risk for diabetes
(a)Identification
and prevention demonstration projects for persons at high risk for type 2
diabetes
(1)
(A)The
Director of the Centers for Disease Control and Prevention (referred to in this
section as the Director
), in consultation with the Division of
Diabetes Translation and academic centers, shall develop a set of pilot
demonstration projects to evaluate various approaches to—
(i)screening and
identifying persons with pre-diabetes and undiagnosed diabetes; and
(ii)providing
identified persons with access to appropriate lifestyle interventions.
(B)Linkage to
diabetes prevention programSuch pilot projects shall be carried
out with the goal of translating, using lifestyle interventions available in
the community, the Diabetes Prevention Program clinical trial into
interventions to reduce the incidence of type 2 diabetes and its related
complications in the United States population.
(2)
(A)The Director shall provide cooperative agreements and
technical assistance to not more than 10 academic centers partnered with State
or local public health departments to implement, monitor, and evaluate such
pilot programs.
(B)Applicants
shall submit to the Director an application, at such time, in such manner, and
containing such information as the Director may require, including—
(i)information
documenting the risk of the populations to be targeted by this intervention;
and
(ii)information
regarding the methods that shall be used to identify and screen these
populations.
(3)The
cooperative agreements awarded under this subsection shall be awarded for a
2-year period, with the Director having the option to extend cooperative
agreements for an additional 2-year period.
(4)Not
later than 4 years after date of the enactment of the
Diabetes Treatment and Prevention Act of
2007, the Director shall release a report evaluating the
effectiveness of this program.
(5)Authorization
of appropriationsThere are authorized to be appropriated
$10,000,000 to carry out this subsection for each of fiscal years 2008 through
2012.
(b)State
partnerships for surveillance and education
(1)The Secretary, acting through the Director of the Centers
for Disease Control and Prevention, shall engage in partnerships with State and
local health departments to carry out the following activities:
(A)National, State,
and local (to the degree determined by the Secretary) surveillance of the
following items:
(i)The number of
individuals and percentage of the population at risk for developing
diabetes.
(ii)The number of
individuals and percentage of the population who have received diabetes and
high blood glucose screenings.
(iii)Among those
individuals who have been identified with pre-diabetes, the proportion that
have been enrolled into lifestyle programs.
(iv)The availability
of interventions to prevent diabetes, and the access of the population to such
interventions.
(v)The number of
individuals and percentage of population with both newly-diagnosed cases of
diabetes and existing cases of diabetes, as well as the rates of increase or
decrease in newly-diagnosed diabetes.
(vi)Other relevant
factors as determined by the Secretary.
(B)Education and
information campaigns to increase awareness among populations at high risk for
diabetes, health care providers, and the general public, about the importance
of primary prevention, ways to assess personal risk, and how to locate and
access diabetes prevention programs.
(2)Authorization
of appropriationsThere are authorized to be appropriated
$10,000,000 to carry out this subsection for each of fiscal year 2008 through
2012.
(c)Treatment
demonstration projects for co-occurring chronic conditions
(1)The Director, acting through the Division of Diabetes
Translation, shall develop a pilot program to improve treatment for individuals
with diabetes and other co-occurring chronic conditions, such as mental
illness, high blood pressure, or cardiovascular disease, for which treatment
may complicate the treatment for diabetes.
(2)
(A)The Director shall provide cooperative agreements and
technical assistance to not more than 10 academic centers, in partnership with
State and local health departments, to implement, monitor, and evaluate
programs designed to improve health outcomes in individuals with diabetes and
other co-occurring chronic conditions.
(B)Applicants
shall submit to the Director an application, at such time, in such manner, and
containing such information as the Director may require, including information
regarding the co-occurring conditions that shall be the subject of
study.
(C)In
awarding the cooperative agreements under this subsection, the Director shall
give preference for research that focuses on conditions which have a high
prevalence among individuals with diabetes, or for which the treatment involved
has the potential to impact adherence to diabetes treatment regimens and that
builds upon existing work designed to improve the quality of care for patients
with diabetes.
(3)The
cooperative agreements awarded under this subsection shall be awarded for a
2-year period, with the Director having the option to extend cooperative
agreements for an additional 2-year period.
(4)Not
later than 4 years after the date of enactment of the
Diabetes Treatment and Prevention Act of
2007, the Director shall release a report evaluating the
effectiveness of this program in improving the health care outcomes for
individuals with diabetes and other co-occurring chronic conditions.
(5)There
are authorized to be appropriated $10,000,000 to carry out this subsection for
each of fiscal years 2008 through
2012.
.